T
TEMPUS AI, INC. CLASS A COMMON STOCK
NASDAQ: TEM (Tempus AI, Inc.)
Last update: 12 hours ago76.05
5.62 (7.98%)
| Previous Close | 70.43 |
| Volume | 6,267,684 |
| Price / Sales | 9.00 |
| Price / Book | 27.53 |
| 52 Weeks Range |
| Profit Margin | -88.27% |
| Operating Margin (TTM) | -26.93% |
| Diluted EPS (TTM) | -5.16 |
| Quarterly Revenue Growth (YOY) | 75.40% |
| Total Debt/Equity (MRQ) | 262.96% |
| Current Ratio (MRQ) | 1.71 |
| Operating Cash Flow (TTM) | -193.29 M |
| Levered Free Cash Flow (TTM) | 54.30 M |
| Return on Assets (TTM) | -43.89% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | Tempus AI, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | 1.2 |
| Price Volatility | -1.8 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Relative Valuation | NA |
| Financial Health | -1.5 |
| Macro Environment | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | 0.28 |
Select this tab to load the latest available analysis.
|
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 43.27% |
| % Held by Institutions | 38.33% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Amova Asset Management Americas, Inc. | 30 Jun 2026 | 4,089,029 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| EPSTEIN DAVID R | - | 78.48 | -370 | -29,038 |
| FUKUSHIMA RYAN | 78.48 | 78.48 | 99,920 | 7,841,722 |
| LEFKOFSKY ERIC P | - | 72.15 | -250,000 | -18,037,500 |
| Aggregate Net Quantity | -150,450 | |||
| Aggregate Net Value ($) | -10,224,816 | |||
| Aggregate Avg. Buy ($) | 78.48 | |||
| Aggregate Avg. Sell ($) | 72.16 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| FUKUSHIMA RYAN | Officer | 02 Nov 2026 | Acquired (+) | 100,000 | 78.48 | 7,848,000 |
| FUKUSHIMA RYAN | Officer | 02 Nov 2026 | Automatic sell (-) | 80 | 78.48 | 6,278 |
| EPSTEIN DAVID R | Director | 02 Nov 2026 | Automatic sell (-) | 370 | 78.48 | 29,038 |
| LEFKOFSKY ERIC P | Officer | 27 Oct 2026 | Automatic sell (-) | 250,000 | 72.15 | 18,037,500 |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |